Related Experiment Video
Updated: Jul 24, 2025

09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
Efficient multi-fidelity computation of blood coagulation under flow.
Biorxiv : the Preprint Server for Biology
|July 3, 2023
Summary
This study introduces a multi-fidelity modeling approach to efficiently simulate blood clot formation. The new method significantly speeds up complex coagulation cascade simulations while maintaining high accuracy, enabling better analysis of blood flow disorders.
Area of Science:
- Biophysics
- Computational Biology
- Biochemical Engineering
Background:
- Blood clot formation is vital but complex, regulated by the coagulation cascade.
- Simulating this cascade involves computationally intensive partial differential equations (PDEs).
- Existing models struggle with the large size and multi-scale nature of these systems.
Approach:
- A multi-fidelity strategy transforms PDEs into ordinary differential equations (ODEs) based on blood residence time.
- Taylor expansion around the zero-diffusivity limit approximates species concentrations using statistical moments.
- This reduces a system of N PDEs to N ODEs and p PDEs for statistical moments.
Key Points:
- The multi-fidelity approach offers a speedup of over N/p compared to high-fidelity models.
- Low-order models (p=1, p=2) show favorable accuracy, with errors under 16% and 5% respectively.
- This method balances computational cost and accuracy for complex simulations.
Conclusions:
- The multi-fidelity models enable efficient and accurate simulations of coagulation cascades.
- This approach can be applied to analyze coagulation in complex flow scenarios and large reaction networks.
- The methodology is generalizable to other blood flow-affected systems biology networks.
Related Concept Videos
Blood Flow
70.3K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
70.3K
Rapidly Varying Flow
98
Rapidly varying flow (RVF) in open channels is characterized by abrupt changes in flow depth over a short distance, with the rate of depth change relative to distance often approaching unity. These flows are inherently complex due to their transient and multi-dimensional nature, making exact analysis difficult. However, approximate solutions using simplified models provide valuable insights into their behavior.Key Features of Rapidly Varying FlowRVF is commonly observed in scenarios involving...
98
Coagulation
7.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
119
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
119
Autoregulation of Blood Flow
2.4K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.4K

